Viewing Study NCT05731518


Ignite Creation Date: 2025-12-25 @ 5:01 AM
Ignite Modification Date: 2025-12-26 @ 4:02 AM
Study NCT ID: NCT05731518
Status: RECRUITING
Last Update Posted: 2023-07-14
First Post: 2023-01-09
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: SC0245 and Irinotecan in Treating Patients With Relapsed Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
Sponsor: Biocity Biopharmaceutics Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module